https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to SARS. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/ https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/ Tue, 01 Sep 2026 00:00:00 GMT The review offers implications for practice, including communication strategies, training, and supply provision, intended to support policymakers and decision-makers managing IPC during ongoing and future pandemic responses. COVID-19 SARS Influenza Health policy Transmission dynamics Treatment Systematic review https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/ https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/ Tue, 01 Sep 2026 00:00:00 GMT The findings concern a treatment option for immunocompromised patients with persistent infection after monoclonal antibody failure, but the supplied abstract does not establish comparative effectiveness or causality. SARS COVID-19 Vaccination Treatment Systematic review https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/ https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/ Tue, 01 Sep 2026 00:00:00 GMT Clarifying these operational parameters supports more precise therapeutic allocation and establishes a methodological framework for managing future infectious disease crises. SARS COVID-19 Vaccination Treatment Transmission dynamics Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/ Tue, 01 Sep 2026 00:00:00 GMT The findings offer immunogenicity evidence relevant to booster vaccination strategy decisions during Omicron-era outbreaks, with particular relevance to settings where inactivated virus priming is used. COVID-19 SARS Vaccination Outbreak investigation Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/ Tue, 01 Sep 2026 00:00:00 GMT These aggregated results guide international immunization planning and highlight structural improvements needed for future outbreak responses, such as unified research methodologies and integrated health databases. COVID-19 SARS Vaccination Vaccine effectiveness Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/ Tue, 01 Sep 2026 00:00:00 GMT The findings indicate that JN.1 vaccination provided limited additional protection against SARS-CoV-2 infection during a low-incidence period, with modest effectiveness observed in both age groups. The results contribute to understanding the real-world performance of updated COVID-19 vaccines against emerging subvariants. SARS COVID-19 Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-7417-ct-2026-2101-5a39d970/ https://globalinfectiousdisease.com/research/articles/10-7417-ct-2026-2101-5a39d970/ Tue, 01 Sep 2026 00:00:00 GMT The article supports a shift from narrow infection prevention strategies to integrated approaches that address both biological and psychosocial occupational hazards, potentially improving healthcare workforce sustainability and system resilience. COVID-19 SARS Surveillance Outbreak investigation Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-1371-journal-pdig-0001473-f2024cba/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pdig-0001473-f2024cba/ Mon, 31 Aug 2026 00:00:00 GMT Centralizing genomic and clinical data streams allows continuous assessment of viral behavior and transmission networks across a large jurisdiction. The established pipeline offers a replicable template for health departments aiming to strengthen routine variant tracking and resource allocation. SARS COVID-19 Genomic epidemiology Surveillance Transmission dynamics Vaccination Genomic study https://globalinfectiousdisease.com/research/articles/10-1158-2159-8290-cd-26-0403-4efecc0b/ https://globalinfectiousdisease.com/research/articles/10-1158-2159-8290-cd-26-0403-4efecc0b/ Fri, 28 Aug 2026 00:00:00 GMT Within the supplied cancer-care cohorts, the findings do not support interpreting peri-treatment SARS-CoV-2 mRNA vaccination as improving immunotherapy-related survival. The abstract describes the observed early-pandemic association as largely attributable to selection bias involving more favorable-prognosis patients. SARS COVID-19 Vaccination Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/ https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/ Thu, 27 Aug 2026 00:00:00 GMT The review maps the clinical spectrum of an immune-mediated post-infectious neurological syndrome across age groups and common viral triggers, which may inform recognition of ataxia syndromes following infection. COVID-19 SARS Varicella Influenza Zoster Treatment Vaccination Systematic review https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14296-1-f04d486a/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14296-1-f04d486a/ Thu, 27 Aug 2026 00:00:00 GMT The findings suggest that relying on reporting dates in surveillance systems may underestimate real-time transmission intensity and distort epidemic risk assessment in childcare settings, which are high-risk environments for respiratory virus transmission. COVID-19 SARS Surveillance Outbreak investigation Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76465-9-6ca54143/ https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76465-9-6ca54143/ Wed, 26 Aug 2026 00:00:00 GMT The study demonstrates a potential sustained protein-delivery platform and motivates further exploration of transgenic schistosomes as living-foundry therapeutics. SARS COVID-19 Transmission dynamics Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/ https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/ Tue, 25 Aug 2026 00:00:00 GMT The authors propose that community-based screening can help identify asymptomatic viral reservoirs and underreported viral circulation, such as adenovirus, linking viral detection to clinical and economic impact. SARS COVID-19 Influenza Surveillance Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-sbi-2026-103375-5f324c76/ https://globalinfectiousdisease.com/research/articles/10-1016-j-sbi-2026-103375-5f324c76/ Tue, 25 Aug 2026 00:00:00 GMT The article may inform research prioritization around extracellular-vesicle characterization, biomarker development, and therapeutic-platform evaluation for COVID-19 and long COVID. The supplied abstract does not establish clinical effectiveness, population-level impact, or readiness for public-health implementation. COVID-19 SARS Diagnostics Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75748-5-6d7271df/ https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75748-5-6d7271df/ Tue, 25 Aug 2026 00:00:00 GMT The demonstration of shared immune alterations across distinct critical illnesses suggests that similar targeted immunomodulation strategies may benefit multiple patient populations in intensive care settings. COVID-19 SARS Cohort study https://globalinfectiousdisease.com/research/articles/10-1111-1468-5973-70225-854005da/ https://globalinfectiousdisease.com/research/articles/10-1111-1468-5973-70225-854005da/ Tue, 25 Aug 2026 00:00:00 GMT The article offers an analytical account of Taiwan's pandemic preparedness trajectory and identifies conditions under which lessons from one public health crisis transfer (or fail to transfer) to a subsequent one, informing comparative crisis management scholarship. SARS Outbreak investigation Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/ https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/ Tue, 25 Aug 2026 00:00:00 GMT The results emphasize the importance of predictable domestic funding, robust monitoring systems, and sustainable local partnerships to maintain endemic disease control during systemic crises. COVID-19 SARS One Health Treatment Surveillance Health policy Commentary https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2716499-8ada39ff/ https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2716499-8ada39ff/ Mon, 24 Aug 2026 00:00:00 GMT The paper is relevant to outbreak preparedness because it describes a rapid antigen test intended for Nipah virus detection in settings where nucleic-acid testing may be difficult to use. The abstract frames the assay as potentially useful for point-of-care diagnosis in resource-limited contexts. MERS SARS COVID-19 Measles Influenza Diagnostics Outbreak investigation One Health Journal article https://globalinfectiousdisease.com/research/articles/10-1093-intimm-dxag045-315c0bb4/ https://globalinfectiousdisease.com/research/articles/10-1093-intimm-dxag045-315c0bb4/ Mon, 24 Aug 2026 00:00:00 GMT The findings suggest BNT162b2 mRNA vaccination induces both effector and regulatory T cell responses to spike antigen, indicating that Treg co-induction may be important for balancing antiviral immunity with immunoregulation during COVID-19 vaccination. COVID-19 SARS Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-3390-gastroent17030047-7c785cda/ https://globalinfectiousdisease.com/research/articles/10-3390-gastroent17030047-7c785cda/ Mon, 24 Aug 2026 00:00:00 GMT The authors note severe upper GI bleeding is rare in children with SARS-CoV-2 infection and MIS-C, and that bleeding occurred despite continuous PPI prophylaxis, suggesting consideration of risk-factor-based prophylaxis and monitoring of vitamin K-dependent coagulation in critically ill children on high-dose corticosteroids and prolonged broad-spectrum antibiotics. SARS COVID-19 Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1007-s40471-026-00405-w-511150c9/ https://globalinfectiousdisease.com/research/articles/10-1007-s40471-026-00405-w-511150c9/ Fri, 21 Aug 2026 00:00:00 GMT Clarifying the scope and availability of these monitoring frameworks may streamline epidemiological investigations and support more effective emergency management strategies. SARS COVID-19 Influenza Surveillance Outbreak investigation Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1097-md-0000000000050329-08341cfe/ https://globalinfectiousdisease.com/research/articles/10-1097-md-0000000000050329-08341cfe/ Fri, 21 Aug 2026 00:00:00 GMT The familial clustering suggests that genetic factors beyond RANBP2 may predispose individuals to ANE following COVID-19. Early recognition of neurological deterioration and prompt MRI evaluation may enable timely immunomodulatory treatment. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-v18080923-cd6d1a13/ https://globalinfectiousdisease.com/research/articles/10-3390-v18080923-cd6d1a13/ Fri, 21 Aug 2026 00:00:00 GMT The methodology supports large-scale tracking of pharmaceutical resistance and viral adaptation markers, indicating potential value for expanding community-level monitoring initiatives. SARS COVID-19 Surveillance Genomic epidemiology Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-54117-5j8z2m06-37e1c154/ https://globalinfectiousdisease.com/research/articles/10-54117-5j8z2m06-37e1c154/ Fri, 21 Aug 2026 00:00:00 GMT The paper calls for stronger emissions controls, cleaner energy policies, and further multidisciplinary research based on its proposed framework. These are recommendations made by the authors and are not independently validated by the supplied evidence. COVID-19 SARS Climate and environment Transmission dynamics Commentary https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1846973-b86af0be/ https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1846973-b86af0be/ Thu, 20 Aug 2026 00:00:00 GMT The work addresses how putative epistatic spike mutations in XBB.1.16 may contribute to immune evasion and variant dominance, relevant to understanding SARS-CoV-2 evolutionary trajectories. SARS COVID-19 Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-1128-aem-00757-26-05c365cd/ https://globalinfectiousdisease.com/research/articles/10-1128-aem-00757-26-05c365cd/ Wed, 19 Aug 2026 00:00:00 GMT Implementing affordable environmental monitoring could strengthen early warning capabilities within congregate living arrangements. Establishing standardized operational procedures alongside environmental tracking may improve institutional readiness during infectious disease events. SARS COVID-19 Influenza Surveillance Outbreak investigation Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13588-w-e7170c47/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13588-w-e7170c47/ Wed, 19 Aug 2026 00:00:00 GMT Findings suggest nirmatrelvir/ritonavir may reduce risks of both acute severe outcomes and post-acute sequelae including long-COVID in high-risk outpatient populations, supporting continued use as a therapeutic option. COVID-19 SARS Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01549-y-025f7ccf/ https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01549-y-025f7ccf/ Tue, 18 Aug 2026 00:00:00 GMT The reported durability and breadth of the cellular response suggest a potential strategy to overcome the immune evasion and waning protection associated with current spike-focused immunizations. COVID-19 SARS MERS Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00401-26-8ade0a81/ https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00401-26-8ade0a81/ Tue, 18 Aug 2026 00:00:00 GMT The abstract highlights a four-fold higher incidence of pulmonary PASC among those with type 2 diabetes and positions GLP-1 receptor agonists as a candidate therapeutic strategy in this population. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s43168-026-00652-x-17423b60/ https://globalinfectiousdisease.com/research/articles/10-1186-s43168-026-00652-x-17423b60/ Tue, 18 Aug 2026 00:00:00 GMT The study identifies potential therapeutic targets for reducing SARS-CoV-2 infection risk in NSCLC patients through modulation of receptor expression, particularly ACE2 and TMPRSS2. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-29303-jbt-v26i3-12221-4e73c5cb/ https://globalinfectiousdisease.com/research/articles/10-29303-jbt-v26i3-12221-4e73c5cb/ Tue, 18 Aug 2026 00:00:00 GMT The findings provide computational evidence for prioritizing carotenoid–RdRp interactions in early antiviral research involving Pandanus conoideus. They do not establish antiviral activity, therapeutic effectiveness, or relevance to patient outcomes. SARS COVID-19 Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1854041-de0c12b1/ https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1854041-de0c12b1/ Tue, 18 Aug 2026 00:00:00 GMT Sustained environmental tracking may offer supplementary insights for anticipating healthcare resource requirements and monitoring ongoing respiratory pathogen circulation. SARS COVID-19 Surveillance Outbreak investigation Vaccination Climate and environment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-medicina62081584-c6ea2e78/ https://globalinfectiousdisease.com/research/articles/10-3390-medicina62081584-c6ea2e78/ Tue, 18 Aug 2026 00:00:00 GMT Identifying specific demographic and treatment-related markers of nutritional decline supports the development of focused monitoring protocols for vulnerable oncology populations during extended public health emergencies. COVID-19 SARS Transmission dynamics Vaccination Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080709-dbfd1331/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080709-dbfd1331/ Tue, 18 Aug 2026 00:00:00 GMT The discussion addresses persistent worldwide influenza burdens and outlines practical barriers to broad deployment, including production volume, financial constraints, temperature-controlled storage demands, and equitable international distribution. Influenza SARS COVID-19 Vaccination Surveillance Commentary https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/ Mon, 17 Aug 2026 00:00:00 GMT The findings can inform decision-making, public health strategies, and policy development to protect vaccinated populations at elevated risk. The results support recommendations from Canada's National Advisory Committee on Immunisation for specific groups to remain current with COVID-19 vaccination to reduce severe outcomes. COVID-19 SARS Vaccination Health policy Cohort study https://globalinfectiousdisease.com/research/articles/10-36560-19520262250-15044241/ https://globalinfectiousdisease.com/research/articles/10-36560-19520262250-15044241/ Mon, 17 Aug 2026 00:00:00 GMT The article describes demographic, clinical, vaccination, medication, comorbidity, and blood-type characteristics among older adults with confirmed COVID-19 in one municipality. These details may provide local context for editorial assessment of COVID-19-related research involving older populations. COVID-19 SARS Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-52600-2763-583x-bjcr-2026-6-1-bjcr219-3ab7c583/ https://globalinfectiousdisease.com/research/articles/10-52600-2763-583x-bjcr-2026-6-1-bjcr219-3ab7c583/ Sun, 16 Aug 2026 00:00:00 GMT The authors suggest investigating persistent gastrointestinal symptoms after COVID-19 infection, though this is limited to a single case with proposed but unconfirmed pathophysiological mechanisms including altered ACE2 expression, gut dysbiosis, barrier disruption, and post-infectious immune dysregulation. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1021-acsnano-6c08330-0cd3a151/ https://globalinfectiousdisease.com/research/articles/10-1021-acsnano-6c08330-0cd3a151/ Sat, 15 Aug 2026 00:00:00 GMT The findings describe a laboratory platform that may support adaptation of aptamer-based detection tools as SARS-CoV-2 spike sequences change. The supplied evidence does not establish clinical performance, effects on patient outcomes, or effectiveness in public-health surveillance. SARS COVID-19 Outbreak investigation Diagnostics Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080705-edd7b616/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080705-edd7b616/ Sat, 15 Aug 2026 00:00:00 GMT The synthesized data offers practical guidance for structuring future immunization initiatives and allocating resources to improve coverage in older adult populations. Influenza SARS COVID-19 Vaccination Vaccine safety Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109062-7d805aff/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109062-7d805aff/ Sat, 01 Aug 2026 00:00:00 GMT Incorporating supplementary information streams into routine monitoring networks may strengthen anticipatory capabilities for future viral circulation waves. COVID-19 SARS Surveillance Transmission dynamics Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106784-7587e5cb/ https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106784-7587e5cb/ Sat, 01 Aug 2026 00:00:00 GMT The documented compatibility indicates potential administrative advantages for coordinating seasonal and shingles immunisations within standard adult care pathways. COVID-19 Influenza Zoster SARS Vaccination Treatment Randomised controlled trial https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128725-c1232c3d/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128725-c1232c3d/ Sat, 01 Aug 2026 00:00:00 GMT Continuous tracking of self-reported tolerability complements traditional clinical trial metrics and supports ongoing evaluation of emerging immunization products. Identifying engagement drop-offs informs strategy development for sustaining participant involvement during future public health emergencies. COVID-19 SARS Vaccination Surveillance Vaccine safety Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128786-fdce4611/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128786-fdce4611/ Sat, 01 Aug 2026 00:00:00 GMT The findings demonstrate that KP.2 vaccine provides meaningful but short-lived protection against COVID-19 hospitalization in older adults, informing vaccination timing and booster strategies for this vulnerable population. COVID-19 SARS Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128821-769efdf1/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128821-769efdf1/ Sat, 01 Aug 2026 00:00:00 GMT Contemporaneous incidence estimates for 30 safety outcomes across five organ systems can inform benefit-risk framing for new and existing respiratory vaccines during the COVID-19 endemic era and highlight the need to account for age and sex when interpreting expected rates. COVID-19 Influenza SARS Vaccination Surveillance Vaccine safety Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128825-7a56d639/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128825-7a56d639/ Sat, 01 Aug 2026 00:00:00 GMT Regulatory measures appear capable of producing temporary shifts in immunization behavior, underscoring the value of strategic communication and phased implementation to preserve coverage during administrative changes. COVID-19 SARS Vaccination Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128827-b7dbe6e5/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128827-b7dbe6e5/ Sat, 01 Aug 2026 00:00:00 GMT Documenting the strength of misinformation-driven immunization reluctance in a resource-limited context underscores the potential utility of tailored communication approaches for upcoming health crises. COVID-19 SARS Vaccination Cross-sectional study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128847-1a3be2a6/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128847-1a3be2a6/ Sat, 01 Aug 2026 00:00:00 GMT The findings underscore how parental immunization perspectives shape broader pediatric preventive care patterns within American households. COVID-19 SARS Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128861-8f95ac35/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128861-8f95ac35/ Sat, 01 Aug 2026 00:00:00 GMT The study addresses vaccine selection in a population at high risk for severe COVID-19, providing comparative immunogenicity data that may inform vaccine choice for maintenance hemodialysis patients. SARS COVID-19 Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128868-6b4dc9ed/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128868-6b4dc9ed/ Sat, 01 Aug 2026 00:00:00 GMT The findings provide context on observed hospitalization and mortality patterns among laboratory-confirmed Omicron cases according to documented prior immunity profiles in this Iranian registry population. The analysis does not estimate protection against acquiring infection. SARS COVID-19 Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128870-0aa7ff23/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128870-0aa7ff23/ Sat, 01 Aug 2026 00:00:00 GMT The work explores alternative delivery methods intended to strengthen localized immune defenses against respiratory pathogens, highlighting areas for future clinical development. SARS COVID-19 Vaccination Treatment Randomised controlled trial